Presentation is loading. Please wait.

Presentation is loading. Please wait.

Is Screening for Atrial Fibrillation in Canadian Family Practices Cost-Effective in Patients 65 Years and Older?  Jean-Eric Tarride, PhD, F. Russell Quinn,

Published byThomas Bengtsson Modified over 5 years ago

Similar presentations

Presentation on theme: "Is Screening for Atrial Fibrillation in Canadian Family Practices Cost-Effective in Patients 65 Years and Older?  Jean-Eric Tarride, PhD, F. Russell Quinn,"— Presentation transcript:

1 Is Screening for Atrial Fibrillation in Canadian Family Practices Cost-Effective in Patients 65 Years and Older?  Jean-Eric Tarride, PhD, F. Russell Quinn, MD, PhD, Gord Blackhouse, MSc, MBA, Roopinder K. Sandhu, MD, MPH, Natasha Burke, MSc, David J. Gladstone, MD, PhD, Noah M. Ivers, MD, PhD, Lisa Dolovich, PharmD, Andrea Thornton, BSc, Juliet Nakamya, PhD, Chinthanie Ramasundarahettige, MSc, Paul A. Frydrych, MD, Sam Henein, MD, Ken Ng, MD, Valerie Congdon, MD, Richard V. Birtwhistle, MD, Richard Ward, MD, Jeffrey S. Healey, MSc, MD  Canadian Journal of Cardiology  Volume 34, Issue 11, Pages (November 2018) DOI: /j.cjca Copyright © 2018 The Authors Terms and Conditions

2 Figure 1 Cost-effectiveness acceptability curves. AF, atrial fibrillation; BP-AF, blood pressure machine with AF detection algorithms; QALY, quality-adjusted life-year; screen-BP-AF, screen with a blood pressure machine with AF detection algorithm; screen-PC, screen with 30-second radial pulse check; screen-SL-ECG, screen with single-lead electrocardiogram. Canadian Journal of Cardiology  , DOI: ( /j.cjca ) Copyright © 2018 The Authors Terms and Conditions

Download ppt "Is Screening for Atrial Fibrillation in Canadian Family Practices Cost-Effective in Patients 65 Years and Older?  Jean-Eric Tarride, PhD, F. Russell Quinn,"

Similar presentations

Sex- and Gender-Related Risk Factor Burden in Patients With Premature Acute Coronary Syndrome Jin Choi, MSc, Stella Styliani Daskalopoulou, MD, MSc, PhD,

Sex- and Gender-Related Risk Factor Burden in Patients With Premature Acute Coronary Syndrome Jin Choi, MSc, Stella Styliani Daskalopoulou, MD, MSc, PhD,
Diabetes Management in Long-Term Care: An Exploratory Study of the Current Practices and Processes to Managing Frail Elderly Persons with Type 2 Diabetes.

Diabetes Management in Long-Term Care: An Exploratory Study of the Current Practices and Processes to Managing Frail Elderly Persons with Type 2 Diabetes.
Health Benefits of Nordic Walking

Health Benefits of Nordic Walking
Current and Future Status of Extracorporeal Cardiopulmonary Resuscitation for In- Hospital Cardiac Arrest  Rohit K. Singal, MD, MSc, Deepa Singal, MSc,

Current and Future Status of Extracorporeal Cardiopulmonary Resuscitation for In- Hospital Cardiac Arrest  Rohit K. Singal, MD, MSc, Deepa Singal, MSc,
CHA2DS2-VASC and CHADS2 Scores Predict Adverse Clinical Events in Patients With Pacemakers and Sinus Node Dysfunction Independent of Atrial Fibrillation 

CHA2DS2-VASC and CHADS2 Scores Predict Adverse Clinical Events in Patients With Pacemakers and Sinus Node Dysfunction Independent of Atrial Fibrillation 
Kiran Sidhu, MD, FRCPC, Anthony Tang, MD, FRCPC 

Kiran Sidhu, MD, FRCPC, Anthony Tang, MD, FRCPC 
Aligning Health Care Policy With Evidence-Based Medicine: The Case for Funding Direct Oral Anticoagulants in Atrial Fibrillation  James A. Stone, MD,

Aligning Health Care Policy With Evidence-Based Medicine: The Case for Funding Direct Oral Anticoagulants in Atrial Fibrillation  James A. Stone, MD,
Long-Term Population-Based Cerebral Ischemic Event and Cognitive Outcomes of Direct Oral Anticoagulants Compared With Warfarin Among Long-term Anticoagulated.

Long-Term Population-Based Cerebral Ischemic Event and Cognitive Outcomes of Direct Oral Anticoagulants Compared With Warfarin Among Long-term Anticoagulated.
Volume 14, Issue 8, Pages e218-e254 (August 2017)

Volume 14, Issue 8, Pages e218-e254 (August 2017)
171 The risk stratification and stroke prevention therapy care gap in canadian atrial fibrillation patients: Insights from the Facilitating Review and.

171 The risk stratification and stroke prevention therapy care gap in canadian atrial fibrillation patients: Insights from the Facilitating Review and.
Values and Preferences of Physicians and Patients With Nonvalvular Atrial Fibrillation Who Receive Oral Anticoagulation Therapy for Stroke Prevention 

Values and Preferences of Physicians and Patients With Nonvalvular Atrial Fibrillation Who Receive Oral Anticoagulation Therapy for Stroke Prevention 
Frontiers of anticoagulation therapy for atrial fibrillation

Frontiers of anticoagulation therapy for atrial fibrillation
Differences and trends in stroke prevention anticoagulation in primary care vs cardiology specialty management of new atrial fibrillation: The Retrospective.

Differences and trends in stroke prevention anticoagulation in primary care vs cardiology specialty management of new atrial fibrillation: The Retrospective.
Patients’ time in therapeutic range on warfarin among US patients with atrial fibrillation: Results from ORBIT-AF registry  Sean D. Pokorney, MD, MBA,

Patients’ time in therapeutic range on warfarin among US patients with atrial fibrillation: Results from ORBIT-AF registry  Sean D. Pokorney, MD, MBA,
The Evolution of Myocardial Infarction: When the Truths We Hold To Be Self-Evident No Longer Have Evidence  David D. Waters, MD, Sripal Bangalore, MD,

The Evolution of Myocardial Infarction: When the Truths We Hold To Be Self-Evident No Longer Have Evidence  David D. Waters, MD, Sripal Bangalore, MD,
Canadian Cardiovascular Society/Canadian Cardiovascular Critical Care Society/Canadian Association of Interventional Cardiology Position Statement on.

Canadian Cardiovascular Society/Canadian Cardiovascular Critical Care Society/Canadian Association of Interventional Cardiology Position Statement on.
Long-term Low-Molecular-Weight Heparin versus Usual Care in Proximal-Vein Thrombosis Patients with Cancer  Russell D. Hull, MBBS, MSc, Graham F. Pineo,

Long-term Low-Molecular-Weight Heparin versus Usual Care in Proximal-Vein Thrombosis Patients with Cancer  Russell D. Hull, MBBS, MSc, Graham F. Pineo,
Canadian Cardiovascular Society Guidelines on the Use of Cardiac Resynchronization Therapy: Implementation  Ratika Parkash, MD, MSc, François Philippon,

Canadian Cardiovascular Society Guidelines on the Use of Cardiac Resynchronization Therapy: Implementation  Ratika Parkash, MD, MSc, François Philippon,
2016 Focused Update of the Canadian Cardiovascular Society Guidelines for the Management of Atrial Fibrillation  Laurent Macle, MD, John Cairns, MD, Kori.

2016 Focused Update of the Canadian Cardiovascular Society Guidelines for the Management of Atrial Fibrillation  Laurent Macle, MD, John Cairns, MD, Kori.
Canadian cost-utility analysis of initiation and maintenance treatment with anti-TNF-α drugs for refractory Crohn's disease  Gord Blackhouse, Nazila Assasi,

Canadian cost-utility analysis of initiation and maintenance treatment with anti-TNF-α drugs for refractory Crohn's disease  Gord Blackhouse, Nazila Assasi,

Similar presentations

Ads by Google